pfizer

AMA Update 287: COVID-19, strep, STDs and Marburg cases on the rise with Andrea Garcia, JD, MPH

AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, covers the latest on coronavirus variant XBB.1.16 and FDA’s authorization changes for Moderna and Pfizer’s bivalent vaccines. Also discussing the rise of strep cases, increases in sexually transmitted diseases and infections. Plus what physicians and patients need to know about abortion pill rulings including the Biden Administrations emergency appeal along with Justice Samuel Alito issuing an administrative stay regarding mifepristone. American Medical Association CXO Todd Unger hosts.

Physicians can consult the American Academy of Pediatrics (AAP) guidance for alternative therapies during the shortage, here: https://www.aap.org/en/pages/amoxicillin-shortage-antibiotic-options-for-common-pediatric-conditions/

Read More

AMA Update 284: Mifepristone, Marburg virus, new COVID variant and RSV vaccine news with Andrea Garcia, JD, MPH

AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, covers the latest on the Marburg virus outbreak, new coronavirus variants XBB.1.16 and XBB.1.9.1, plus Pfizer’s RSV vaccine. Also discussing what physicians and patients need to know about Texas US District Judge Matthew Kacsmaryk’s ruling to suspend the FDA’s approval of mifepristone. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 252: The latest research on long COVID symptoms, treatments & more with Andrea Garcia, JD, MPH

AMA’s Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, discusses the latest research on long COVID, as well as #omicron variant XBB.1.5 and other #SARSCoV2 subvariants. Also covering how the Biden Administration’s decision to end COVID-19 national emergency and U.S. public health emergency on May 11 will affect hospitals, physicians and patients—while the World Health Organization (WHO) maintains the COVID-19 pandemic is still a global health emergency. American Medical Association CXO Todd Unger hosts.

Watch, read, or listen to Sandra Fryhofer, MD, AMA Board Chair’s recent #vaccine and bivalent booster episode, here: https://www.ama-assn.org/delivering-care/public-health/bivalent-vaccine-effectiveness-covid-booster-schedule-and-evusheld

Read More

AMA Update 245: ‘Kraken’ variant & vaccine stroke risk: everything you need to know with Sandra Fryhofer, MD

The latest on Pfizer’s COVID vaccine and stroke risk. Sandra Fryhofer, MD, breaks down vaccine safety statistics following new #FDA and #CDC announcements about possible increased risk of stroke after getting Pfizer’s bivalent booster shot. Also covering VSD, other #vaccine databases, and what’s expected at the Vaccines and Related Biological Products Advisory Committee (VBRPAC) meeting this January. Plus everything you need to know about the ‘Kraken’ — a.k.a, the XBB.1.5 #omicron variant. American Medical Association CXO Todd Unger hosts #AMAUpdate

Read More

AMA Update 244: Vaccine stroke risk, new MIS-C data & pediatric vaccine decline with Andrea Garcia, JD, MPH

AMA’s Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, discusses recent release by CDC, FDA regarding possible link between Pfizer’s bivalent booster and stroke risk for those 65 and older. Also covering the potential increased risk of measles, mumps and rubella (MMR) for kindergartners given a decrease in pediatric vaccinations this year, as well as new findings regarding multisystem inflammatory syndrome (MIS-C) in children. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update Welcome to the AMA Update

The AMA Update podcast covers a range of health care topics affecting the lives of physicians and patients. Hear from physicians and experts on COVID-19, monkeypox, advocacy issues, scope of practice, and more. Because who’s doing the talking matters. Find all AMA podcasts at ama-assn.org/podcasts

Read More

AMA Update 170: Jynneos, Tpoxx & federal services for long COVID with Andrea Garcia, JD, MPH

AMA Director of Science, Medicine and Public Health, Andrea Garcia JD, MPH, covers monkeypox cases, vaccines, Tecovirimat used for treatment, as well as two Biden administration reports and support services for Americans with long haul COVID. American Medical Association CXO Todd Unger hosts.

Visit https://www.covid.gov/longcovid for federal services and supports for people experiencing longer term impacts of COVID-19.

Access guidance and descriptors for new monkeypox CPT codes here: https://www.ama-assn.org/practice-management/cpt/orthopoxvirus-and-monkeypox-coding-guidance

Read More

AMA Update 158: FDA and CDC back COVID vaccines for youngest kids with Andrea Garcia, JD, MPH

AMA CXO Todd Unger discusses the latest on COVID vaccines for kids under 5 with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering progress on Moderna’s and Pfizer’s EUAs, and identifying questions parents might have for physicians about getting their kids vaccinated.

Read More

AMA Update 157: Andrea Garcia, JD, MPH, on when the youngest kids can get vaccinated

AMA CXO Todd Unger discusses FDA timeline on Pfizer & Moderna vaccines for the youngest children with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the FDA advisory committee’s recommendations for kids ages 6 to 17, news on a possible booster for fall, as well as the lifting of testing requirements for international travel to the U.S.

Read More

AMA Update 146: FDA to review COVID vaccine for kids under 5 with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews the latest timeline on Moderna and Pfizer vaccine authorizations for young children with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the rise in COVID cases, FDA’s proposed timing to review data on Novavax and variant-specific vaccines, as well as how to spot fake COVID-19 at-home tests.

Read More